Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20047935HPVENSG00000163485.18protein_codingADORA1NoNo134P30542
TVIS20068926HPVENSG00000163485.18protein_codingADORA1NoNo134P30542
TVIS44043593HTLV-1ENSG00000163485.18protein_codingADORA1NoNo134P30542
TCGA Plot Options
Drug Information
GeneADORA1
DrugBank IDDB00201
Drug NameCaffeine
Target IDBE0000013
UniProt IDP30542
Regulation Typeantagonist
PubMed IDs16702031; 17372967; 17126319; 17162470; 17085856
CitationsGaytan SP, Saadani-Makki F, Bodineau L, Frugiere A, Larnicol N, Pasaro R: Effect of postnatal exposure to caffeine on the pattern of adenosine A1 receptor distribution in respiration-related nuclei of the rat brainstem. Auton Neurosci. 2006 Jun 30;126-127:339-46. Epub 2006 May 15.@@Wang SJ: Caffeine facilitation of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) through activation protein kinase C pathway: an interaction with presynaptic adenosine A1 receptors. Synapse. 2007 Jun;61(6):401-11.@@Rieg T, Schnermann J, Vallon V: Adenosine A1 receptors determine effects of caffeine on total fluid intake but not caffeine appetite. Eur J Pharmacol. 2007 Jan 26;555(2-3):174-7. Epub 2006 Oct 25.@@Mustafa S, Venkatesh P, Pasha K, Mullangi R, Srinivas NR: Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF? Xenobiotica. 2006 Dec;36(12):1239-58.@@Listos J, Malec D, Fidecka S: Adenosine receptor antagonists intensify the benzodiazepine withdrawal signs in mice. Pharmacol Rep. 2006 Sep-Oct;58(5):643-51.
GroupsApproved
Direct ClassificationXanthines
SMILESCN1C=NC2=C1C(=O)N(C)C(=O)N2C
PathwaysCaffeine Metabolism
PharmGKBPA448710
ChEMBLCHEMBL113